Connect with us

Health

Lagos Launches Public Health Campaign on Mpox

Published

on

The Lagos State Government has unveiled a series of comprehensive public health initiatives.

These are in response to the growing global concern over the Mpox virus, particularly the newly identified Clade 1B variant.

During a media briefing held at Protea Hotel, Alausa Ikeja, the State Commissioner for Health, Prof. Akin Abayomi, outlined the state’s multipronged strategy to shield Lagos from this emerging threat.

Prof. Abayomi announced three significant milestones as part of Lagos State’s public health strategy against Mpox.

The first is a robust stakeholder engagement involving experts from various sectors to discuss Mpox and its management, both locally and globally.

Although Lagos has no active cases at present, however, the risk posed by the more aggressive Clade 1B variant remains a significant concern due to Lagos’s extensive travel connections.

The second milestone is the activation of an Emergency Operations Centre (EOC) specifically dedicated to monitoring and addressing the Mpox outbreak, with a particular focus on the Clade 1B variant.

The third milestone is the launch of a statewide public health awareness campaign aimed at educating residents about the risks associated with Mpox and preventive measures they can take.

The Commissioner emphasized the current concern over the Clade 1B variant, which is rapidly spreading across Central Africa, particularly in the Democratic Republic of Congo (DRC), and has now reached neighboring countries like Cameroon, Rwanda, and Burundi.

“This variant is distinct from the indigenous Clade 2 variant, which has been detected sporadically in West Africa. Although Lagos has no active cases at present, however, the risk posed by the more aggressive Clade 1B variant remains a significant concern due to Lagos’s extensive travel connections.

The World Health Organization (WHO) has declared the outbreak in the DRC a Public Health Emergency of International Concern, highlighting the need for a coordinated global response”, he said.

Prof. Abayomi noted that Lagos State is taking proactive steps, drawing on its experience with past health crises like Ebola, COVID-19, cholera, and Lassa fever. According to him, these measures aim to prevent the introduction of the Clade 1B variant into Lagos, which could have severe health and economic implications.

The Commissioner explained that Mpox, like smallpox and cowpox, is a zoonotic disease that initially spreads from animals to humans, particularly through rodents and monkeys.

Human-to-human transmission occurs through close contact, with the Clade 1B variant showing a higher transmission rate, especially through sexual contact.

Prof. Abayomi warned that while there are currently no active Mpox cases in Lagos, the state must remain vigilant against the potential importation of this aggressive variant.

He disclosed that a mini-symposium on Mpox which was held before the media briefing, featured insights from global health experts, including representatives from WHO, UNICEF, the Nigeria Centre for Disease Control (NCDC), Nigeria Institute of Medical Research (NIMR), LUTH and LASUTH. “These experts discussed the risks posed by the Clade 1B variant to Lagos and the steps needed to create a biological shield against the virus.

The collective goal is to ensure that Lagos is fully prepared to manage any potential outbreak and minimize its impact”, Prof. Abayomi said.

While noting that Lagos State’s high population density and extensive travel links make it particularly vulnerable to the rapid spread of contagious diseases, the Commissioner urged the public and healthcare providers to be vigilant and prepared to recognize, diagnose, and manage Mpox cases effectively.

“The activation of the EOC and the launch of the public awareness campaign are critical components of this strategy.

As part of the proactive measures, a comprehensive public health awareness campaign has been rolled out across Lagos. This campaign seeks to inform the public about the symptoms of Mpox, such as fever, joint pain, body aches, and distinctive rashes.

Residents are urged to report any suspicious symptoms to the nearest health facility for prompt evaluation”, he stated.

Prof. Abayomi  noted that Lagos State is also exploring vaccine options and has established local research teams to guide government policy on Mpox. These efforts aim to bolster the state’s preparedness for a possible outbreak and ensure a swift and effective response.

The Commissioner noted that despite the absence of active Mpox cases in Lagos, the state government is committed to maintaining a high level of preparedness. Prof. Abayomi expressed gratitude to all partners and collaborators for their continued support in these efforts, stressing the importance of collective action in safeguarding Lagos from the potential dangers of Mpox.

Speaking in the same vein, the Director of Epidemiology, Biosecurity, and Global Health in the Lagos State Ministry of Health, Dr. Ismail Abdus-Salam provided detailed information on the symptoms of the Clade 1B variant.
He highlighted the severity of the rashes caused by this variant, particularly those that appear in the genital area, which are more painful and pronounced than typical Mpox rashes.

Dr. Abdus-Salam emphasized the critical need for early identification and containment of Mpox cases to prevent the spread of the Clade 1B variant within Lagos. “The state’s public health systems are on high alert, ready to act swiftly to protect residents from this virulent strain”, he said.

Lagos State’s comprehensive and proactive approach to public health sets a precedent for other regions to follow.

The state’s ongoing efforts to prevent the importation and spread of Mpox, particularly the Clade 1B variant, demonstrate its commitment to protecting the health and well-being of its residents in the face of emerging global health threats.

Health

JUST IN: Ogun confirms Lassa fever outbreak as NYSC member dies

Published

on

A 25-year-old member of the National Youth Service Corp (NYSC), has reportedly died of Lassa fever at a secondary health facility in ljebu North Local Government Area of Ogun State.

It wwas learnt that the female corp member who fell sick while in Ondo State, was brought to the health facility last Tuesday and later died same day.

This was contained in a statement signed by the Commissioner for Health, Tomi Coker, on Wednesday.

Coker also confirmed the outbreak of Lassa fever in the state.

The statement reads, “Ogun State has confirmed a case of Lassa Fever and as such declared Lassa fever outbreak.

“The index case is a 25-year-old female National Youth Corp member who fell sick while in Ondo State and was brought to on of our secondary health facility in ljebu North LGA on 18th March 2025 and later died same day.

“ Lassa fever is a viral Haemorrhagic disease that presents with High grade fever, Headache, General body weakness, Sore throat, Muscle pain, Cough, Nausea, Vomiting, Diarrhoea, Chest pain and Unexplained bleeding from the ears, eyes, nose, mouth and other body openings.

”Coker urged members of the community to report to the hospital if any of the listed symptoms is noticed.

“We implore members of the community to promptly report to the hospital if they notice any of these symptoms.

Any case of febrile illness that has not responded to 48 hours use of anti-malaria or antibiotics should raise an index of suspicion for Lassa fever!

“We implore all Health facilities in Ogun State, public and private, to step up Infection Prevention and Control measures and to encourage compliance by all health facility staff.“

Healthcare worker that suspects Lassa fever in a patient, are advised to call their local government disease surveillance and notification officer (LGA DSNO) whose numbers are placed in our health facilities or call State Disease surveillance and Notification Officer (0703-421-4893) or State Epidemiologist (0808-425-0881),” she added.

The commissioner, however reiterated the Governor Dapo Abiodun-led administration’s dedication to protecting the health of the citizens through continuous surveillance and prompt response to infectious diseases.

She added that the ministry in collaboration with the Rapid Response Team at ljebu North East is keeping the situation under control with enhanced surveillance and community engagement and mobilization for effective response.

Continue Reading

Health

JUST IN: NAFDAC goes digital in fight against fake pharmaceutical products

Published

on

The National Agency for Food and Drug Administration and Control, NAFDAC, has gone digital in its efforts to rid the country of substandard and falsified pharmaceutical products.

During a two-day workshop and training session in Port Harcourt, Rivers State, on Wednesday, NAFDAC introduced an app, Greenbook, an online platform for identifying the source of a product.

The Greenbook allows consumers to enter the product name, brand name, or registration number to search for information about its registration status.

If the product is listed in the Greenbook, it signifies that it has been registered by NAFDAC and is considered authentic.

The app serves as a tool to help consumers identify and avoid potentially fake or substandard products.

The Director-General of NAFDAC, Prof. Mojisola Adeyeye, speaking at the workshop in Port Harcourt, stated that these fake products are “produced by our greedy businessmen and their international collaborators to get rich or make money,” describing it as the worst form of inhumanity of man to his fellow men.

Prof. Adeyeye, who was represented by the Director of the Post-Marketing Surveillance Directorate, NAFDAC, Fraden Bitrus, noted that the agency has, over the years, deployed various measures to combat falsified products.

She expressed concern that counterfeiters have adopted increasingly sophisticated methods to advance their trade but assured that NAFDAC “is poised to use technologies and modern means to mitigate the activities of counterfeiters, hence the need for stakeholder sensitisation.”

She added that the workshop aims to educate stakeholders and provide hands-on training on the NAFDAC Greenbook, the Traceability Regulation 2024, and the Paediatric Regulation 2024, ensuring that both the regulator and the regulated are aligned in the fight against substandard and falsified medical products.

Prof. Adeyeye revealed that the project is being implemented in phases, initially used for COVID-19 vaccine distribution as a pilot project, which yielded highly effective results.

She noted, “Within 24 hours, batches of substandard or defective vaccines distributed in the country were traced and recalled.”

She further stated, “We have implemented it for commodities in public health, such as antimalarial and narcotic products.

Over time, we will extend it to other products. Please note that with this technology, stakeholders can detect and reject SF products before they enter the supply chain.”

She called on all stakeholders in the healthcare sector to support these initiatives to combat fake products and ensure the availability of quality, safe, and efficacious medical products for the people of Nigeria.

Continue Reading

Health

IPOB to NAFDAC: Return seized goods from Onitsha drug market

Published

on

The Indigenous People of Biafra (IPOB) has called on the National Agency for Food and Drug Administration and Control (NAFDAC) to return goods seized from traders at Ogbo Ogwu Drug Market in Onitsha, Anambra State.

In a statement issued by IPOB’s Media and Publicity Secretary, Comrade Emma Powerful, the group alleged that NAFDAC officials conducted a midnight raid on the market, blocking CCTV cameras, breaking into shops, and confiscating goods under the claim of targeting fake drugs.

IPOB criticized the method of the operation, questioning the agency’s approach and transparency.

While IPOB reaffirmed its stance against the sale of counterfeit drugs, it raised concerns over the alleged seizure of traders’ goods in their absence, the blocking of surveillance cameras, and the lack of evidence proving that all confiscated products were counterfeit.

The group posed several questions to NAFDAC, including: Why was the operation conducted at midnight? Why were CCTV cameras blocked?

Where is the evidence that the confiscated drugs were fake? Why was the entire market sealed, affecting both innocent and guilty traders?

IPOB urged NAFDAC to adopt a more professional and transparent approach to combating fake drugs, suggesting that the agency establish permanent offices in drug markets to ensure proper regulation rather than conducting surprise raids.

The statement also called for collaboration between NAFDAC and the Anambra State Government to relocate the drug market to the new Oba Drug Market, ensuring that only licensed and certified dealers are allowed to operate.

Continue Reading

Trending